Sergio Leal

Sergio Leal

Company: Bayer

Job title: Director, Global Clinical Leader


Aflibercept – Longer Lasting, Higher Dose to Optimize Treatment 9:30 am

Translating learnings from the aflibercept 8 mg program to improve treatment delivery and sustain disease control when treating Wet AMD, DME and DR Addressing the potential risks and side effects when developing higher dose formulationRead more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.